Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Research Grant Award

4 Apr 2013 07:00

RNS Number : 5270B
Biome Technologies PLC
04 April 2013
 



04 April 2013

 

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Research Grant Award

 

A consortium led by Biome Technologies has been awarded a grant by the UK's innovation agency, the Technology Strategy Board (TSB) to investigate a bio-based alternative for the oil derived organic chemicals used in the manufacturer of bioplastics.

 

The research will be undertaken by the group's bioplastic division Biome Bioplastics, one of the UK's leading developers of natural plastics, in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining.

 

The £150,000 grant has been made as part of the TSB's 'Sustainable high value chemical manufacture through industrial biotechnology' technical feasability competition, which funds projects that apply sustainable biobased feedstocks and biocatalytic processes in the production of chemicals.

 

Biome has partnered with the University of Warwick's Centre for Biotechnology and Biorefining that is pioneering academic research into lignin degrading bacteria. Biome is working with the Warwick team to develop methods to control the lignin breakdown process to determine whether these chemicals can be extracted in significant quantities and used in the synthesis of bioplastics.

 

The TSB grant will support an initial feasibility project to isolate a chemical from lignin to replace the oil-derived equivalent currently used in a polyester that conveys strength and flexibility in some of Biome's products. The production of such a bio-based polyester would reduce the cost and further enhance the sustainability of these products. This project is in line with Biome's strategy of identifying ways to accelerate business in the area of synthetic biology, without depleting the Group's cash resources with the full development costs.

 

"The environmental and social concerns surrounding the use of fossil fuels and food crops make lignin a compelling target as a source of chemicals", explains Professor Tim Bugg, Director of the Centre."Often considered a waste product, it may provide a sustainable source of building blocks for aromatic chemicals that can be used in bioplastics."

 

If the initial feasibility assessment is successful, building on this work, Biome will explore the possibilities for deriving a wide selection of bio-based aromatic chemicals from lignin, further reducing cost and expanding bioplastic functionality.

 

"The bioplastics market remains small compared to that of fossil based polymers", comments Biome Technologies CEO Paul Mines. "Growth is restricted by the price of bioplastic resins being 2-4 times that of their petrochemical counterparts. We anticipate that the availability of a high performance polymer, manufactured economically from renewable sources could increase the market considerably."

 

Further information on Biome's work with lignin can be found at www.biometechnologiesplc.co.uk.

 

-Ends-

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

David Hart

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

First Columbus

Chris Crawford/Kelly Gardiner

www.first-columbus.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters/Latika Shah

Tel: +44 (0) 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUGUCGCUPWGBW
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.